Skip to main content
    Q

    Quest Diagnostics Incorporated (DGX)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $256.36
    -5.85 (-2.23%)

    Market Cap: $28.85B

    Last updated: Nov 17, 2026 at 4:24 PM ET

    Quest Diagnostics Incorporated (DGX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Quest Diagnostics (DGX) has a latest price of $256.36 on Nov 17, 2026, 2.6% below its 52-week high of $263.19. Its price rose 38.3% over the past 12 months. The month-end price rose 209.2% over the 10 years through Oct 2026, a compound annual rate of 12.0%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $251.82 in Oct 2026 and its lowest $80.30 in Mar 2020, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart DGX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DGX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 6.4%, and over 6 months it rose 35.7%. The month-end price rose 93.6% over the 3 years through Oct 2026, a compound annual rate of 24.6%.

    PeriodChange
    1 month+9.1%
    3 months+6.4%
    6 months+35.7%
    12 months+38.3%
    12 months, with dividends+40.2%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+93.6%+24.6%
    5 years+71.6%+11.4%
    10 years+209.2%+12.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2021, when the price rose 45.2%, and its weakest was 2018, when it fell 15.5%.

    YearCloseChange
    2026 through Oct 2026$251.82+45.1%
    2025$173.53+15.0%
    2024$150.86+9.4%
    2023$137.88-11.9%
    2022$156.44-9.6%
    2021$173.01+45.2%
    2020$119.17+11.6%
    2019$106.79+28.2%
    2018$83.27-15.5%
    2017$98.49+7.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 6.0% above its 50-day average of $241.88 and 19.0% above its 200-day average of $215.45.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$256.36
    52-week high$263.19-2.6%
    52-week low$168.34+52.3%
    50-day average$241.88+6.0%
    200-day average$215.45+19.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 12.4%.

    MeasureValue
    1-year beta-0.06
    Largest fall, 1 year-11.9%
    Largest fall, 3 years-12.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Quest Diagnostics traded at 17.6x earnings at the end of 2025, against a 5-year median of 16.2x and a 10-year median of 16.5x.

    DGX valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About DGX

    What is DGX's 1-year price change?

    Quest Diagnostics's price rose 38.3% over the past 12 months. With dividends included, the 12-month total return was 40.2%.

    What is DGX's 5-year price change?

    Quest Diagnostics's month-end price rose 71.6% over the 5 years through Oct 2026, a compound annual rate of 11.4%. These figures leave out dividends.

    What is DGX's 52-week high and low?

    Quest Diagnostics's 52-week high is $263.19 and its 52-week low is $168.34. Its latest price of $256.36 on Nov 17, 2026 is 2.6% below the high.

    What is DGX's beta?

    Quest Diagnostics's 1-year beta against the S&P 500 is -0.06, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 11.9%.

    Is the DGX chart free?

    Yes. Advanced Charting for DGX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.